Variants of concern of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have shown the ability to avoid vaccine-induced and natural immunity. The Delta variant is now responsible for over 90% of new cases. In a study published in the New England Journal of Medicine, researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.
